Bellerophon Therapeutics, Inc. to Issue Dividend of $0.02 (NASDAQ:BLPH)

Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) declared a dividend on Tuesday, December 17th,investing.com reports. Stockholders of record on Friday, December 20th will be given a dividend of 0.019 per share by the biotechnology company on Wednesday, December 18th. This represents a dividend yield of 117.8%. The ex-dividend date of this dividend is Thursday, December 19th.

Bellerophon Therapeutics Price Performance

BLPH stock opened at $0.02 on Tuesday. Bellerophon Therapeutics has a 1-year low of $0.01 and a 1-year high of $0.02. The business has a fifty day moving average price of $0.04 and a 200-day moving average price of $0.04. The stock has a market capitalization of $196,951.30, a P/E ratio of -0.02 and a beta of 0.74.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on Bellerophon Therapeutics in a research report on Tuesday, December 10th. They set a “hold” rating for the company.

About Bellerophon Therapeutics

Bellerophon Therapeutics, Inc, a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension.